BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8862963)

  • 1. Adverse effects of thyroid hormone preparations and antithyroid drugs.
    Bartalena L; Bogazzi F; Martino E
    Drug Saf; 1996 Jul; 15(1):53-63. PubMed ID: 8862963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacotherapy of hyperthyreosis--adverse drug reactions].
    Perger L; Bürgi U; Fattinger K
    Ther Umsch; 2011 Jun; 68(6):303-8. PubMed ID: 21656488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S; Khan M; Kumar N; Mohan V
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbimazole-induced agranulocytosis--a report of 2 recent cases.
    Tavintharan S; Rajasoorya C; Chew LS
    Singapore Med J; 1997 Sep; 38(9):386-7. PubMed ID: 9407764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients].
    Meyer-Gessner M; Benker G; Olbricht T; Windeck R; Cissewski K; Reiners C; Reinwein D
    Dtsch Med Wochenschr; 1989 Feb; 114(5):166-71. PubMed ID: 2464468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
    Pearce SH
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):589-94. PubMed ID: 15521961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of medications and hormones used in the treatment of pediatric thyroid disorders.
    Beck-Peccoz P; Persani L; LaFranchi S
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():124-33. PubMed ID: 16456491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis.
    Cheung CL; Sing CW; Tang CS; Cheng VK; Pirmohamed M; Choi CH; Hung CS; Lau EY; Lee KF; Mak MW; Leung JY; Wong TW; Ho AY; Chan KW; Hung V; Tam V; Siu SC; Pang HK; Wat WZ; Lee HH; Chung CT; Hue RS; Sham PC; Cheung BM; Wong IC; Tan KC; Kung A
    Clin Pharmacol Ther; 2016 May; 99(5):555-61. PubMed ID: 26599303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P; Osborne NJ; Sturley R; Vaidya B
    QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
    Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.